Compound ID | 807
Class: Oxazolidinone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Protein synthesis inhibitor; Effective against MRSA and PRSP |
Institute where first reported: | Dong-A Pharmaceutical, Republic of Korea |
Year first mentioned: | 2000 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
External links: | |
Citation: |